Atlas Trials

Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients

Clinical trial NCT00473577 · COMPLETED

Trial details

NCT number
NCT00473577
Sponsor
Pharmacyclics LLC.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hematologic NeoplasmsNeoplasms
Start date
2005-08-01
Primary completion
2007-11-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.